Annual CFO:
$13.55M+$72.81M(+122.86%)Summary
- As of today, SPRY annual cash from operations is $13.55 million, with the most recent change of +$72.81 million (+122.86%) on December 31, 2024.
- During the last 3 years, SPRY annual cash from operations has risen by +$31.11 million (+177.15%).
- SPRY annual cash from operations is now at all-time high.
Performance
SPRY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$47.05M-$7.46M(-18.83%)Summary
- As of today, SPRY quarterly cash from operations is -$47.05 million, with the most recent change of -$7.46 million (-18.83%) on September 30, 2025.
- Over the past year, SPRY quarterly cash from operations has dropped by -$32.58 million (-225.20%).
- SPRY quarterly cash from operations is now -212.01% below its all-time high of $42.00 million, reached on December 31, 2024.
Performance
SPRY Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$85.38M-$32.58M(-61.71%)Summary
- As of today, SPRY TTM cash from operations is -$85.38 million, with the most recent change of -$32.58 million (-61.71%) on September 30, 2025.
- Over the past year, SPRY TTM cash from operations has dropped by -$39.52 million (-86.16%).
- SPRY TTM cash from operations is now -730.18% below its all-time high of $13.55 million, reached on December 31, 2024.
Performance
SPRY TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SPRY Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +122.9% | -225.2% | -86.2% |
| 3Y3 Years | +177.2% | -728.0% | -108.8% |
| 5Y5 Years | +171.7% | - | - |
SPRY Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +122.9% | -212.0% | at low | -730.2% | at low |
| 5Y | 5-Year | at high | +122.9% | -212.0% | at low | -730.2% | at low |
| All-Time | All-Time | at high | +122.9% | -212.0% | at low | -730.2% | at low |
SPRY Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$47.05M(-18.8%) | -$85.38M(-61.7%) |
| Jun 2025 | - | -$39.59M(+2.8%) | -$52.80M(-157.7%) |
| Mar 2025 | - | -$40.74M(-197.0%) | -$20.48M(-251.2%) |
| Dec 2024 | $13.55M(+122.9%) | $42.00M(+390.3%) | $13.55M(+129.5%) |
| Sep 2024 | - | -$14.47M(-98.7%) | -$45.86M(-3.9%) |
| Jun 2024 | - | -$7.28M(-8.5%) | -$44.16M(+17.5%) |
| Mar 2024 | - | -$6.71M(+61.4%) | -$53.55M(+9.6%) |
| Dec 2023 | -$59.27M(-47.9%) | -$17.41M(-36.4%) | -$59.27M(-41.6%) |
| Sep 2023 | - | -$12.76M(+23.4%) | -$41.86M(-20.4%) |
| Jun 2023 | - | -$16.67M(-34.1%) | -$34.78M(-38.6%) |
| Mar 2023 | - | -$12.43M(-118.7%) | -$25.09M(+38.6%) |
| Dec 2022 | -$40.08M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$5.68M(+18.5%) | -$40.89M(+24.7%) |
| Jun 2022 | - | -$6.97M(-0.7%) | -$54.32M(+11.6%) |
| Mar 2022 | - | -$6.92M(+67.5%) | -$61.48M(+7.9%) |
| Dec 2021 | -$17.56M(+43.7%) | - | - |
| Dec 2021 | - | -$21.30M(-11.4%) | -$66.76M(-46.9%) |
| Sep 2021 | - | -$19.12M(-35.3%) | -$45.45M(-72.6%) |
| Jun 2021 | - | -$14.13M(-15.9%) | -$26.34M(-49.3%) |
| Mar 2021 | - | -$12.20M(-124.2%) | -$17.64M(-35.0%) |
| Dec 2020 | -$31.20M(-65.1%) | - | - |
| Jun 2020 | - | -$5.44M(+28.6%) | -$13.07M(-71.4%) |
| Mar 2020 | - | -$7.63M | -$7.63M |
| Dec 2019 | -$18.90M(-12.0%) | - | - |
| Dec 2018 | -$16.88M | - | - |
FAQ
- What is ARS Pharmaceuticals, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. annual cash from operations year-on-year change?
- What is ARS Pharmaceuticals, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
- What is ARS Pharmaceuticals, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
What is ARS Pharmaceuticals, Inc. annual cash from operations?
The current annual cash from operations of SPRY is $13.55M
What is the all-time high annual cash from operations for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high annual cash from operations is $13.55M
What is ARS Pharmaceuticals, Inc. annual cash from operations year-on-year change?
Over the past year, SPRY annual cash from operations has changed by +$72.81M (+122.86%)
What is ARS Pharmaceuticals, Inc. quarterly cash from operations?
The current quarterly cash from operations of SPRY is -$47.05M
What is the all-time high quarterly cash from operations for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high quarterly cash from operations is $42.00M
What is ARS Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
Over the past year, SPRY quarterly cash from operations has changed by -$32.58M (-225.20%)
What is ARS Pharmaceuticals, Inc. TTM cash from operations?
The current TTM cash from operations of SPRY is -$85.38M
What is the all-time high TTM cash from operations for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high TTM cash from operations is $13.55M
What is ARS Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
Over the past year, SPRY TTM cash from operations has changed by -$39.52M (-86.16%)